Mucinose Folicular: revisão da literatura e relato de um caso Follicular mucinosis: literature review and case report

A mucinose follicular (MuF), também chamada de alopecia mucinosa, é mucinose cutânea caracterizada pelo acúmulo de mucina no folículo pilossebáceo. As mucinoses têm duas formas de apresentação: uma idiopática ou primária, e outra sintomática ou associada a diversos processos benignos e malignos. Os autores apresentam um caso de mucinose folicular primária e fazem breve revisão do assunto. Trata-se de uma paciente de 26 anos de idade, com placa eritematosa recoberta por fina descamação, alopécica e localizada no supercílio direito. Após seis meses, sem qualquer tratamento, houve resolução espontânea da lesão. A paciente permaneceu durante 12 meses em controle ambulatorial sem que se evidenciasse qualquer sinal de recidiva.<br>Follicular mucinosis, also known as alopecia mucinosa, is a cutaneous mucinosis characterized by mucin accumulation predominantly in the pilosebaceous follicle. Two forms are distinguished: an idiopathic, or primary form, which is benign and without associated disease, and a symptomatic form associated with lymphoproliferative disorder, most commonly the cutaneous T-cell lymphoma mycosis fungoides. The authors present a new case of the disease and a brief review of the literature. The patient was a 26-year-old female with an asymptomatic plaque of erythema and scaling with alopecia on her right eyebrow. The lesion resolved spontaneously six months later. We have followed the patient over twelve months without relapse

Management of primary cicatricial alopecias: Options for treatment

Primary cicatricial alopecias (PCAs) are a poorly understood group of disorders that result in permanent hair loss. Clinically, they are characterized not only by permanent loss of hair shafts but also of visible follicular ostia along with other visible changes in skin surface morphology, while their histopathological hallmark usually (although not always) is the replacement of follicular structures with scar-like fibrous tissue. As hair follicle neogenesis in adult human scalp skin is not yet a readily available treatment option for patients with cicatricial alopecias, the aim of treatment, currently, remains to reduce symptoms and to slow or stop PCA progression, namely the scarring process. Early treatment is the key to minimizing the extent of permanent alopecia. However, inconsistent terminology, poorly defined clinical end-points and a lack of good quality clinical trials have long made management of these conditions very challenging. As one important step towards improving the management of this under-investigated and under-serviced group of dermatoses, the current review presents evidence-based guidance for treatment, with identification of the strength of evidence, and a brief overview of clinical features of each condition. Wherever only insufficient evidence-based advice on PCA management can be given at present, this is indicated so as to highlight important gaps in our clinical knowledge that call for concerted efforts to close these in the near future.</p